According to REGENXBIO's latest financial reports the company's total debt is A$0.12 Billion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-12-31 | A$0.13 B | 0.63% |
2023-12-31 | A$0.13 B | -5.92% |
2022-12-31 | A$0.13 B | 16.51% |
2021-12-31 | A$0.11 B | 26.54% |
2020-12-31 | A$94.48 M | 485.69% |
2019-12-31 | A$16.13 M | 94.14% |
2018-12-31 | A$8.3 M | |
2017-12-31 | N/A | |
2014-12-31 | A$2.93 M | |
2013-12-31 | N/A |
Company | Total debt/th> | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | A$4.93 M | -95.98% | ๐บ๐ธ USA |